论文信息 - Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines.

Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridines.

The synthesis and evaluation of tetrasubstituted aminopyridines, bearing novel azaindazole hinge binders, as potent AKT inhibitors are described. Compound 14c was identified as a potent AKT inhibitor that demonstrated reduced CYP450 inhibition and an improved developability profile compared to those of previously described trisubstituted pyridines. It also displayed dose-dependent inhibition of both phosphorylation of GSK3beta and tumor growth in a BT474 tumor xenograft model in mice.

[1] W. K. Fife. Regioselective cyanation of pyridine 1-oxides with trimethylsilanecarbonitrile: a modified Reissert-Henze reaction , 1983 .

[2] D. Misner,et al. Assessing hERG channel inhibition using PatchXpress. , 2007, Clinics in laboratory medicine.

[3] G. Warren,et al. Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. , 2008, Journal of medicinal chemistry.

[4] L. Lafrance,et al. A facile method for the synthesis of substituted pyrazolo[3,4-c]pyridines , 2009 .

[5] O. Anisimova,et al. ω-Substituted-2-(polyenamino)- or annelated nitropyridines from 1-(3-cyano-5-nitropyridyl-2)-pyridinium salts , 1998 .

[6] P. Moeller,et al. Unusual reactions of magnesium indolates with benzenesulfonyl chloride , 1987 .

[7] P. Lam,et al. Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants. , 2003, Journal of medicinal chemistry.